Skip to main content
Premium Trial:

Request an Annual Quote

SAIC-Frederick Taps Silicon Kinetics Technology for Protein Interaction Research

NEW YORK (GenomeWeb News) – SAIC-Frederick will use Silicon Kinetics’ technology platform to study protein interactions in cancer and AIDS and to determine how drugs affect those interactions, Silicon Kinetics said today.
Under the agreement, National Cancer Institute contractor SAIC-Frederick will use Silicon Kinetics’ three-dimensional, label-free SKi Pro Biomolecular Interaction Analysis Platform in its Protein Chemistry Laboratory to study extracellular binding domains of specific proteins linked to these diseases.
The partnership was struck through the NCI’s Advanced Technology Partnerships Initiative, which is focused on translating research discoveries into treatments for AIDS and cancer patients.
The SKi Pro platform combines nanoporous silicon and optical interferometry to study proteins on 3D biosensor surfaces, Silicon Kinetics said.
The company said that the SKi Pro platform and its SKi Sensor biochips are used to detect protein-protein, protein-drug, or protein-DNA interactions in real time, quantifying binding kinetics, and for other studies of disease pathways and in therapeutic development.
Financial terms of the agreement were not released.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.